SILDENAFIL CITRATE
- Product NDC
- 72603-885
- 11-digit product format
- 726030885
- Labeler code
- 72603
- Product ID
- 72603-885_4bb9baea-3bd6-03c0-e063-6294a90a218a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- SILDENAFIL CITRATE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Northstar Rx LLC
- Application
- ANDA209302
- Marketing category
- ANDA
- Marketing start
- 2026-02-24
- Substance
- SILDENAFIL CITRATE
- Active strength
- 100 mg/1
- Pharmacologic classes
- Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- SILDENAFIL CITRATE
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| SILDENAFIL CITRATE | 100 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | BW9B0ZE037 |
| Rxcui | 312950, 314228, 314229 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 72603-885-01 | SILDENAFIL CITRATE | 30 in 1 BOTTLE | TABLET | 30 | | 1 |
| 72603-885-02 | SILDENAFIL CITRATE | 100 in 1 BOTTLE | TABLET | 100 | | 1 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 72603-885-01 | 72603088501 | 30 TABLET in 1 BOTTLE (72603-885-01) | 30 tablet | 2026-02-24 | No | No | Current |
| 72603-885-02 | 72603088502 | 100 TABLET in 1 BOTTLE (72603-885-02) | 100 tablet | 2026-02-24 | No | No | Current |